Stanley C Erck

Mr. Erck applies his 25 years of management experience in the healthcare and biotechnology industry (Baxter International, Procept and Integrated Genetics) to shepherd the development and commercialization of Iomai technology. In addition to successfully negotiating major alliances with pharmaceutical and biotechnology companies and bringing products into clinical trials, as CEO he has managed the process of developing companies from private funding through public offerings. Mr. Erck received his B.S. from the University of Illinois and an M.B.A. from the University of Chicago.